Tuberculosis Flashcards
The following agents are used in the treatment of XDR-TB (Extreme drug resistance)
a. ethambutol
A. True, resistance to isoniazid, rifampicin and fluoroquinolone (floxacin)
The following agents are used in the treatment of XDR-TB (Extreme drug resistance)
b. isoniazid
B. False, resistance to isoniazid, rifampicin and fluoroquinolone (floxacin)
The following agents are used in the treatment of XDR-TB (Extreme drug resistance)
c. rifampicin
C. False, resistance to isoniazid, rifampicin and fluoroquinolone (floxacin)
The following agents are used in the treatment of XDR-TB (Extreme drug resistance)
d. pyrazinamide
D. True, resistance to isoniazid, rifampicin and fluoroquinolone (floxacin)
The following agents are used in the treatment of XDR-TB (Extreme drug resistance)
e. streptomycin
E. True
Agents used in the management of Mycobacteria tuberculosis
a. isoniazid causes peripheral neuropathy as an adverse effect
A. True, hepatitis and peripheral neuropathy
Agents used in the management of Mycobacteria tuberculosis
b. rifampicin inhibits cell wall synthesis
B. False, rifampicin inhibits RNA synthesis
Agents used in the management of Mycobacteria tuberculosis
c. ethambutol causes gout
C. True, ethambutol and pyrazinamide cause hyperuriceamia which can lead to gout
Agents used in the management of Mycobacteria tuberculosis
d. streptomycin is safe to use during pregnancy
D. False. Teratogenic
Agents used in the management of Mycobacteria tuberculosis
e. pyrazinamide is hepatotoxic
E. True, pyrazinamide, isoniazid and rifampicin are hepatotoxic
In the treatment of tuberculosis, Isoniazid
a. is activated by catalase peroxidase (KatG)
A. True, isoniazid is a pro drug, activated by mycobacterial KatG
In the treatment of tuberculosis, Isoniazid
b. stimulates mycobacterial mycolic acid synthesis
B. False. Inhibits mycobacterial mycolic acid synthesis
In the treatment of tuberculosis, Isoniazid
c. is activated against intracellular mycobacteria
C. True, intra and extracellular
In the treatment of tuberculosis, Isoniazid
d. -induced peripheral neuropathy is treated with pyridoxine
D. True
In the treatment of tuberculosis, Isoniazid
e. induces cytochrome P450 enzymes
E. False. Inhibits cytochrome P450 enzymes
In the treatment of tuberculosis, rifampicin
a. inhibits mycobacterial RNA synthesis
A. True.
In the treatment of tuberculosis, rifampicin
b. causes contraceptive failure in women taking the combined oral contraceptive pill
B. True, rifampicin induces CYP450 enzymes. This will result in decreased concentrations of the combined oral contraceptive
In the treatment of tuberculosis, rifampicin
c. inhibits the metabolism of warfarin
C. False, induces CYP450 enzymes increased metabolism of warfarin
In the treatment of tuberculosis, rifampicin
d. is bacteriostatic
D. False, only ethambutol is bacteriostatic
In the treatment of tuberculosis, rifampicin
e. causes an orange discolouration to body fluids
E. True
Rifampicin
a. inhibits cytochrome P450 enzymes
A. False, induces
Rifampicin
b. is used as an alternative to ciprofloxacin for prophylaxis against meningococcal infections
B. True.
Rifampicin
c. causes hepatotoxicity
C. True, pyrazinamide, isoniazid and rifampicin are hepatotoxic
Rifampicin
d. is used in the treatment of tuberculosis during pregnancy
D. True. During pregnancy give standard 6 month regiment
Rifampicin
e. enhances mycobacterial RNA synthesis
E. False. Inhibit RNA synthesis
Antimycobacterial agents
a. isoniazid causes peripheral neuropathy
A. True, causes peripheral neuropathy and hepatitis
Antimycobacterial agents
b. pyrazinamide decreases serum uric acid levels
B. False. Pyrazinamide and ethambutol cause hyperuricaemia